Singleton, P. | bioRxiv Science

bioRxiv2025

Cocaine use disorder is associated with lower brain state transition energy particularly in higher order and excitatory networks

Cocaine use disorder (CUD) detrimentally impacts personal health, social relationships, and economic opportunity. Here, we assess CUD-associated shifts in brain dynamics using Network Control Theory and examine how they align with previously identified changes in neurological systems and behavioral profiles of people with CUD. The SUDMEX CONN dataset consists of multi-modal MRI, cocaine use metrics, behavioral measures, and demographics of individuals with CUD (N=132, 71 CUD). We identified recurring brain activity states and used NCT to calculate the transition energy (TE) between pairs of states. ANCOVAs examined global and regional TE associations with drug use group (CUD vs controls (NC)), years of CUD, and risk-taking behaviors. We identified potential mechanisms driving the differences by correlating CUD-related regional TE effects with neurotransmitter/receptor systems. People with CUD had significantly lower global TE and default mode, dorsal attention and limbic network TE compared to non-user controls, particularly in regions enriched for noradrenaline and mu opioid receptors. Longer duration of CUD was associated with more decreased global TE, top-down TE, default mode, control and ventral attention network TE, and regional TE enriched for excitatory neurotransmitters and receptors. People with CUD needed to expend more global and top-down TE to perform better on a risk-taking task (the Iowa Gambling task), an effect which was not found in NCs. Our analysis of whole-brain activity dynamics provides a link between the effects of upstream glutamatergic excitotoxicity and/or opioid receptor dysfunction, and downstream weakening of inhibitory control that is central to CUD.

neuroscience↗

bioRxiv2024

The forgotten psychedelic: Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybin

As psychedelic-assisted psychotherapy gains momentum, clinical investigation of next-generation psychedelics may lead to novel compounds tailored for specific populations. 2,5-dimethoxy-4-bromophenethylamine (2C-B) is a psychedelic phenethylamine reported to produce less dysphoria and subjective impairment than the psychedelic tryptamine psilocybin. Despite its popularity among recreational users and distinct pharmacodynamics, the neural correlates of 2C-B remain unexplored. Using 7T resting-state functional MRI in 22 healthy volunteers, we mapped out the acute effects of matched doses of 20 mg 2C-B, 15 mg psilocybin and placebo across spatiotemporal benchmarks of functional brain organisation. In a within-subjects, double-blind, placebo-controlled crossover design, we evaluated the neuropharmacological and neurobehavioural correlates of an array of connectivity measures - including static (sFC) and global connectivity (gFC), dynamic connectivity variability (dFC), and spontaneous brain complexity. Compared to placebo, 2C-B and psilocybin selectively reduced intra-network sFC, while broadly increasing between-network and subcortical-cortical connectivity. Compared to psilocybin, 2C-B exhibited less pronounced reductions in between-network FC but elicited elevations in transmodal sFC. Both compounds yielded spatially divergent increases in gFC yet produced similar increases in brain complexity. Using PET density modelling, the spatial distribution of neural effects aligned with documented differences in monoaminergic transporter and serotonergic receptor binding affinity beyond 5-HT2A, highlighting the role of pharmacology in shaping functional dynamics. Lastly, we show behavioural markers of psychedelic effects are non-linearly reflected by the desynchronisation of the transmodal axis of functional brain organisation. Together, our findings highlight 2C-B as a useful new addition to the study of psychedelic neuroscience and may motivate new pharmacotherapy strategies.

neuroscience↗